Halozyme shares surge 6% on strong Q4 results, upbeat 2025 outlook By...

Published on 19 Feb 2025 on Investing.com

Halozyme shares surge 6% on strong Q4 results, upbeat 2025 outlook

Read the rest of the article

Start tracking your investments with Statfolio

Halozyme shares surge 6% on strong Q4 results, upbeat 2025 outlook

Investing.com 19 Feb 2025

Release Date: February 18, 2025 For the complete transcript of the earnings call, please refer to...

GuruFocus.com · via Yahoo Finance 19 Feb 2025

However, the growth potential is expected to have been partially offset by lower Kuvan sales. BMR...

Zacks · via Yahoo Finance 17 Feb 2025

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we ...

Insider Monkey · via Yahoo Finance 12 Feb 2025

Investors in Halozyme Therapeutics, Inc. HALO need to pay close attention to the stock based on...

Zacks · via Yahoo Finance 9 Jan 2025

Shares of Halozyme Therapeutics, Inc. HALO were up 5% on Jan. 8 after the company raised its...

Zacks · via Yahoo Finance 9 Jan 2025

LDOS, Amazon.com, Inc. AMZN, Halozyme Therapeutics, Inc. HALO and BioMarin Pharmaceutical Inc. BM...

Zacks · via Yahoo Finance 7 Jan 2025

Halozyme Therapeutics, Inc. HALO announced that it has withdrawn its non-binding proposal to acqu...

Zacks · via Yahoo Finance 25 Nov 2024

Have a confidential tip for our reporters? Halozyme Therapeutics Inc. withdrew its bid to purchas...

Bloomberg 22 Nov 2024

Halozyme Therapeutics, Inc. (NASDAQ:HALO) saw its shares rise on Friday after the company announc...

Benzinga · via Yahoo Finance 22 Nov 2024